More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents (MOCHA)
Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This PHASE1/PHASE2 trial investigates HIV Infections and is currently completed. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 39 recorded versions since 2019 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
39 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE1/PHASE2
-
Oct 2025 — Feb 2026 [monthly]
Completed PHASE1/PHASE2
-
Aug 2025 — Oct 2025 [monthly]
Completed PHASE1/PHASE2
Status: Active Not Recruiting → Completed
-
Oct 2024 — Aug 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
▶ Show 34 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2023 — Jun 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2023 — Sep 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2023 — Jul 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2023 — Mar 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2022 — Jan 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2022 — Oct 2022 [monthly]
Recruiting PHASE1_PHASE2
-
May 2022 — Jul 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2022 — May 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2021 — Feb 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2021 — Dec 2021 [monthly]
Recruiting PHASE1_PHASE2
Status: Active Not Recruiting → Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2020 — May 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2019 — Jan 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2019 — Aug 2019 [monthly]
Recruiting PHASE1_PHASE2
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Feb 2019 — Mar 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
May 2018 — Aug 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
- ViiV Healthcare
For direct contact, visit the study record on ClinicalTrials.gov .